Soluble interleukin-20 receptor
AssigneeZymoGenetics, Inc.
InventorsDONALD C. FOSTER, WENFENG XU, KAREN L. MADDEN, JAMES D. KELLY, CINDY A. SPRECHER, CAMERON S. BRANDT, MARK W. RIXON, SCOTT R. PRESNELL, BRIAN A. FOX
Life of this patent
Estimating the term…
Abstract
A soluble receptor to IL-20 having two polypeptide subunits, IL-20RA (formerly called ZcytoR7) and IL-20RB (formerly called DIRS1). The two subunits are preferably linked together. In one embodiment one subunit is fused to the constant region of the light chain of an immunoglobulin, and the other subunit is fused to the constant region of the heavy chain of the immunoglobulin. The light chain and the heavy chain are connected via a disulfide bond.
Claims13
A method of treating an inflammatory disease in a subject in need thereof, comprising:
- administering to the subject an effective amount of an antibody that specifically binds to an IL-20 receptor comprising an IL-20RA subunit and an IL-20RB subunit, wherein the IL-20A subunit comprises a polypeptide having the amino acid sequence of SEQ ID NO:
- 11 and the IL-20RB subunit comprises a polypeptide having the amino acid sequence of SEQ ID NO:
- 14.
A method of treating an inflammatory disease in a subject in need thereof, comprising:
- administering to the subject an effective amount of an antibody that specifically binds to an IL-20 receptor comprising an IL-20RA subunit and an IL-20RB subunit, wherein the IL-20A subunit comprises a polypeptide having the amino acid sequence of SEQ ID NO:
- 12 and the IL-20RB subunit comprises a polypeptide having the amino acid sequence of SEQ ID NO:
- 15.
A method of treating an inflammatory disease in a subject in need thereof, comprising:
- administering to the subject an effective amount of an antibody that specifically binds to an IL-20 receptor comprising an IL-20RA subunit and an IL-20RB subunit, wherein the IL-20A subunit comprises a polypeptide having the amino acid sequence of SEQ ID NO:
- 55 and the IL-20RB subunit comprises a polypeptide having the amino acid sequence of SEQ ID NO:
- 59.
Dependencies are inferred from the claim text.